Open original FDA record ↗Recall record
- FDA identifier
- Z-3129-2011
- Company in FDA record
- bioMerieux, Inc.
- FDA classification date
- Sep 2, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Complaints were received of high rates of false positive results, leading to unnecessary antibiotic therapy being prescribed to patients.
Source facts
- Action
- bioMerieux sent an "URGENT PRODUCT REMOVAL NOTICE" letter dated July 8, 2011 to all affected customers. The letter describes the product, problem, and the actions to be taken by the customers. The letter instructs customers to discontinue using and to destroy any of the affected product. The firm advises customers to confirm all positive results obtained with the affected lot number with another method prior to reporting results. An Acknowledgement and Product Replacement form was attached for customers to complete and return to the firm. Customers should contact their local bioMerieux Customer Service representative for questions regarding this notice.
- Initiated
- 2011-07-08
- Root cause
- Other
- Terminated
- 2012-10-23
- Distribution
- Nationwide Distribution- including CA, DC, FL, IL, IL, IN, MD, MI, MN, MO, MT, NC, NE, NJ, NY, PA, UT, VA and WI.
- Recall number
- Z-3129-2011
- Recall status
- Terminated
- CDRH record ID
- 103183
- FDA classified
- 2011-09-02
- Recall event number
- 59601